Jason Lettmann - 08 Sep 2023 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Executive Officer, Director
Signature
/s/ Peter Garcia, by power of attorney
Issuer symbol
ALXO
Transactions as of
08 Sep 2023
Net transactions value
$0
Form type
4
Filing time
12 Sep 2023, 16:24:52 UTC
Previous filing
22 Jun 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option (right to buy) Award $0 +1,200,000 $0.000000 1,200,000 08 Sep 2023 Common Stock 1,200,000 $4.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vest on September 5, 2024 and 1/48th of the shares vest monthly thereafter.